Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Excellent Outcomes with Brentuximab-Nivolumab for Relapsed/ Refractory Primary Mediastinal B-Cell Lymphoma in the Real-World Setting

Lucy Pickard, Li Yuan Chan, Su Li, Michael Potter, Emma Nicholson, Ian Chau, David Cunningham, Juanah Addada, Emily Chernucha, Sunil Iyengar, Dima El-Sharkawi

Blood (2024) 144 (Supplement 1): 3085.

https://doi.org/10.1182/blood-2024-204653

Published: 2024

Journal Articles

Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

Farheen Mir, Anna Robinson, Mark Edward Ethell, Michael Potter, Emma Nicholson, Chloe Anthias, Sandra Easdale, Carlos Gonzalez-Arias, Amit Sud, Claire E. Dearden, Ian Chau, David Cunningham, Dima El-Sharkawi, Bhupinder Sharma, Sunil Iyengar

Blood (2022) 140 (Supplement 1): 9366–9367.

https://doi.org/10.1182/blood-2022-166198

Published: 2022

Journal Articles

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cost Evaluation Study of Management and Surveillance, and Review of the Recent USA and UK Guidelines

Aia S Mehdi, Rachel O'Connell, Michael Potter, Chris Marshall, Liza Van Kerckhoven, Sunil Iyengar, Emma Nicholson, Dima El-Sharkawi, Marios Tasoulis, David Cunningham, Bhupinder Sharma

Blood (2021) 138 (Supplement 1): 4014.

https://doi.org/10.1182/blood-2021-153675

Published: 2021

Journal Articles

Comparison of Different Upfront Transplant Strategies in Multiple Myeloma - a Large Registry Study from Chronic Malignancies Working Party of EBMT

Blood (2019) 134 (Supplement_1): 324.

https://doi.org/10.1182/blood-2019-128795

Published: 2019

Journal Articles

Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017

Blood (2019) 134 (Supplement_1): 4575.

https://doi.org/10.1182/blood-2019-127166

Published: 2019

Journal Articles

No Improvement in Survival for T-PLL Patients over the Last Two Decades

Matthew J Cross, MBBS, BSc, Monica Else, Ricardo Morilla, Mark Edward Ethell, MD, Michael Potter, MD, Dima El-Sharkawi, Sunil Iyengar, MBBS, FRCPath, PhD, Claire E. Dearden, MD FRCP, FRCPath

Blood (2019) 134 (Supplement_1): 1552.

https://doi.org/10.1182/blood-2019-122094

Published: 2019

Journal Articles

The Use of Anti-Thymocyte Globulin Is Associated with Decreased Risk of Chronic Graft-Versus-Host Disease without Impact on Survival after Allogeneic Peripheral Blood Stem Cell Transplantation for Adults with Philadelphia-Positive Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 1971.

https://doi.org/10.1182/blood.V130.Suppl_1.1971.1971

Published: 2017

Journal Articles

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Blood (2016) 128 (22): 678.

https://doi.org/10.1182/blood.V128.22.678.678

Published: 2016

Journal Articles

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Sebastian Giebel, Myriam Labopin, MD, Michael Potter, Xavier Poiré, MD, Henrik Sengeloev, MD, Gerard Socié, MD PhD, Anne Huynh, MD, Boris V Afanasyev, Professor, Urs Schanz, MD, Olle Ringden, Peter Kalhs, MD, Dietrich W. Beelen, Prof. Dr. MD, Antonio M. Campos, MD, Tamás Masszi, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler*, MD

Blood (2016) 128 (22): 512.

https://doi.org/10.1182/blood.V128.22.512.512

Published: 2016

Journal Articles

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2016) 128 (22): 993.

https://doi.org/10.1182/blood.V128.22.993.993

Published: 2016

Journal Articles

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Blood (2015) 126 (23): 4399.

https://doi.org/10.1182/blood.V126.23.4399.4399

Published: 2015

Journal Articles

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Blood (2015) 126 (23): 1499.

https://doi.org/10.1182/blood.V126.23.1499.1499

Published: 2015

Journal Articles

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Sonja G Genadieva Stavrik, MDPhD, Ariane Boumendil, Kirsty Thomson, Javier Briones, MD, Paolo Corradini, MD, Andrea Bacigalupo, MD, Gerard Socie, Guiseppe Bandini, Herve Finel, Andrea Velardi, MD, Michael Potter, PhD, Bruno Benedetto, Luca Castagna, MD, Charles Craddock, MDPhD, Nigel Russell, Peter Dreger, MD, Sureda Anna

Blood (2014) 124 (21): 2562.

https://doi.org/10.1182/blood.V124.21.2562.2562

Published: 2014

Journal Articles

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Mary Gleeson, FRCPath, Eliza A Hawkes, MD, Clare Peckitt, MSc, Andrew Wotherspoon, FRCPath, Ayoma Attygalle, PhD, Bhupinder Sharma, MD, Yong Du, MD, Mark Ethell, MD, Michael Potter, PhD, Claire Dearden, MD, Alan Horwich, MD, Ian Chau, MD, David Cunningham, FMedSci

Blood (2014) 124 (21): 1719.

https://doi.org/10.1182/blood.V124.21.1719.1719

Published: 2014

Journal Articles

Successful Long-Term Outcomes in Patients with Lymphoma Achieving Only Partial Response on [ 18 f]FDG-PET Prior to Allogeneic Transplant

Robert N Lown, MBBS, MDRes), MRCP, FRCPath, Anastasia Constantinidou, Caroline Ebdon, Kabir Mohammed, Mark Ethell, MD, Ian Chau, MD, David Cunningham, FMedSci, Michael Potter, PhD, Bhupinder Sharma, MD

Blood (2014) 124 (21): 1249.

https://doi.org/10.1182/blood.V124.21.1249.1249

Published: 2014

Journal Articles

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

Bronwen E. Shaw, PhD MRCP, FRCPath, Neema P Mayor, Szydlo Richard, Will P Bultitude, Kirkland Keiren, Perry Julia, Wilson Marie, Andrew Clark, Stephen Mackinnon, David I Marks, Antonio Pagliuca, MD FRCP, FRCPath, Michael Potter, PhD, Nigel Russell, Kirsty Thomson, J. Alejandro Madrigal, MD PhD, Steven GE Marsh, PhD

Blood (2014) 124 (21): 1207.

https://doi.org/10.1182/blood.V124.21.1207.1207

Published: 2014

Journal Articles

Residual Disease on FDG-PET and Multiple Lines of Prior Therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

Blood (2014) 124 (21): 3971.

https://doi.org/10.1182/blood.V124.21.3971.3971

Published: 2014

Journal Articles

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

Robert N Lown, MD, Steven GE Marsh, PhD, Helen Blake, BSc, Sergio Querol, MD, PhD, Irina Evseeva, PhD, Stephen Mackinnon, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath

Blood (2013) 122 (21): 2138.

https://doi.org/10.1182/blood.V122.21.2138.2138

Published: 2013

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

John A Snowden, MD, FRCP, FRCPath, Robert Danby, MRCP, Annalisa Ruggeri, MD, David I Marks, Rachael E Hough, MD, Antonio Pagliuca, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, Andrew Clark, Eliane Gluckman, MD, Gordon Cook, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Vanderson Rocha, MD, PhD

Blood (2013) 122 (21): 3394.

https://doi.org/10.1182/blood.V122.21.3394.3394

Published: 2013

Journal Articles

EBMT Prospective Non-Interventional Study On Allogeneic Hematopoietic Stem Cell Transplantation In T-Prolymphocytic Leukemia (T-PLL). Preliminary Analysis Of 43 Patients

Wieslaw Wiktor Jedrzejczak, M.D., Ph.D., Simona Iacobelli, Ph. D., Jennifer D.C. Hoek, Ph.D., Joanna E Drozd-Sokolowska, M.D., Ph.D., Michael Potter, MD, PhD, Gerald Wulf, MD, Patrice Chevallier, MD, PhD, Per T. Ljungman, MD, PhD, Yener Koc, MD, Johannes Schetelig, MD, M. Sc, Theo de Witte, MD, Nicolaus Kroeger, MD, Peter Dreger, MD

Blood (2013) 122 (21): 3336.

https://doi.org/10.1182/blood.V122.21.3336.3336

Published: 2013

NARROW

Excellent Outcomes with Brentuximab-Nivolumab for Relapsed/ Refractory Primary Mediastinal B-Cell Lymphoma in the Real-World Setting

Autologous Transplantation in First Remission in the Rituximab Era in Patients with Mantle Cell Lymphoma: Experience from the Royal Marsden Hospital

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cost Evaluation Study of Management and Surveillance, and Review of the Recent USA and UK Guidelines

Comparison of Different Upfront Transplant Strategies in Multiple Myeloma - a Large Registry Study from Chronic Malignancies Working Party of EBMT

Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017

No Improvement in Survival for T-PLL Patients over the Last Two Decades

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Comparable Results of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia in First Complete Molecular Remission: An Analysis By the Acute Leukemia Working Party of the EBMT

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Is Stem Cell Transplantation for Transformed Follicular Lymphoma Required in the Rituximab Era?: The Royal Marsden Experience 2003-2013

Successful Long-Term Outcomes in Patients with Lymphoma Achieving Only Partial Response on [ 18 f]FDG-PET Prior to Allogeneic Transplant

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

Residual Disease on FDG-PET and Multiple Lines of Prior Therapy Predict Poorer Outcomes Following Autologous Hematopoietic Stem Cell Transplantation for Lymphoma

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

EBMT Prospective Non-Interventional Study On Allogeneic Hematopoietic Stem Cell Transplantation In T-Prolymphocytic Leukemia (T-PLL). Preliminary Analysis Of 43 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only